Takuro Okada

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification

Soichiro Takase, Satoshi Kano, Yuichiro Tada et al. · Oncotarget · 2017 · 114 citations · Full text

Medicine, Oncology, Pathology +17

Measurement of bronchial hyperreactivity in infants and preschool children using a new method.

Gyokei Murakami, Tomofumi Igarashi, Yoko Adachi et al. · PubMed · 1990 · 91 citations

Medicine, Child Health, Pediatrics +11

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

Kazutomo Niwa, Daisuke Kawakita, Toshitaka Nagao et al. · Scientific Reports · 2020 · 58 citations · Full text

Medicine, Oncology, Immunotherapy +13

Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas

Tomotaka Shimura, Yuichiro Tada, Hideaki Hirai et al. · Oncotarget · 2017 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Efficacy and safety of nivolumab in 100 patients with recurrent or metastatic head and neck cancer – a retrospective multicentre study

Isaku Okamoto, Hiroki Sato, Takahito Kondo et al. · Acta Oto-Laryngologica · 2019 · 52 citations

Medicine, Oncology, Pharmacology +16